Brought to you by:
Jocelyn Hudson
Final patient treated in Cook’s Zenith Fenestrated+ endovascular graft clinical study
Cook Medical has enrolled the final patient in the global clinical study of its Zenith Fenestrated+ endovascular graft (ZFEN+), signifying completion of patient recruitment in the pivotal study. The investigational ZFEN+ clinical study is being conducted under an Investigational Device Exemption…
FDA deems Envveno’s VenoValve ‘not-approvable’
The Food and Drug Administration (FDA) has issued a letter to Envveno Medical stating that its VenoValve technology is “not-approvable,” a company press release published today reports. The letter was issued in response to Envveno’s premarket approval (PMA) application for…
‘Critical’ importance of lifelong surveillance after EVAR headlines newly published 10-year ENGAGE data
Ten-year data highlight the long-term efficacy and durability of the Endurant stent graft (Medtronic) in abdominal aortic aneurysm (AAA) patients who survived beyond five years post-enrollment in the ENGAGE registry. However, researchers also draw attention to the incidence of late…
First patient enrolled in AngioDynamics’ AMBITION BTK trial for CLTI
AngioDynamics today announced enrollment of the first patient in AMBITION BTK, a randomized study of the Auryon atherectomy system in patients with below-the-knee chronic limb-threatening ischemia (CLTI). A press release details that AMBITION BTK is a prospective, multicenter, randomized controlled…
Danish study suggests patients with AAA could benefit from high-dose statin use
A five-year prospective cohort study—using longitudinal registry data from two population-based screening trials—has found that high-dose statin use was associated with decreased abdominal aortic aneurysm (AAA) growth rates and lowered risk of undergoing repair, rupture, and death. Researchers therefore suggest…
Researchers examine safety of prophylactic spinal fluid drainage in open and endovascular TAA and TAAA patients
“Spinal fluid drainage be considered when the risk of spinal cord injury from the procedure is greater than the risk of severe complications from spinal fluid drainage.” This was one of the concluding findings of a study presented during the…
ATEV shows promise in high-risk patients on hemodialysis
Results from the CLN-PRO-V007 pivotal phase 3 clinical trial of the acellular tissue engineered vessel (ATEV; Humacyte) in arteriovenous access for patients at high risk of autologous arteriovenous fistula (AVF) maturation failure with end-stage renal disease were presented at the…
Award-winning basic science research targets ‘highly complex’ process of vascular calcification
“We were really excited to know that the SVS [Society for Vascular Surgery] is supporting our research,” Sujin Lee, MD, told Vascular Specialist on receiving the SVS Foundation James S.T. Yao Resident Research Award for a paper examining the role of…
‘Rise together’: Harris urges unity in Women’s Vascular Summit presidential address
Society for Vascular Surgery (SVS) Vice President Linda Harris, MD, extolled the values of “co-elevation” in her presidential address at the 7th annual Women’s Vascular Summit (May 2–3), invoking lessons on teamwork from the world of sport to argue that…
Increased experience with off-the-shelf TAAA endograft sees reduction in complications but no effect on mortality
Michele Piazza, MD, informed attendees of the 2025 Vascular Annual Meeting (VAM) that increased experience with the E-nside (Artivion) off-the-shelf preloaded inner branch endograft for branched endovascular aneurysm repair (BEVAR) leads to a “significant” reduction in intraprocedural complications, but does not…